Protection against avian metapneumovirus subtype C in turkeys immunized via the respiratory tract with inactivated virus.

Vaccine

Department of Veterinary and Biomedical Sciences, University of Minnesota, 1971 Commonwealth Ave., St. Paul, MN 55108, USA.

Published: January 2011


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Avian metapneumovirus subtype C (aMPV/C) causes a severe upper respiratory tract (URT) infection in turkeys. Turkeys were inoculated oculonasally with inactivated aMPV/C adjuvanted with synthetic double-stranded RNA polyriboinosinic polyribocytidylic acid (Poly IC). Immunized turkeys had elevated numbers of mucosal IgA+ cells in the URT and increased levels of virus-specific IgG and IgA in the lachrymal fluid and IgG in the serum. After 7 or 21 days post immunization, turkeys were challenged oculonasally with pathogenic aMPV/C. Immunized groups were protected against respiratory lesions induced by the challenge virus. Further, the viral copy number of the challenge virus in the URT were significantly lower in the immunized turkeys than in the unimmunized turkeys (P<0.05). These results showed that inactivated aMPV/C administered by the respiratory route induced protective immunity against pathogenic virus challenge.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2010.10.074DOI Listing

Publication Analysis

Top Keywords

avian metapneumovirus
8
metapneumovirus subtype
8
respiratory tract
8
immunized turkeys
8
challenge virus
8
turkeys
7
protection avian
4
subtype turkeys
4
immunized
4
turkeys immunized
4

Similar Publications

Epidemiological and phylogenetic characteristics of human metapneumovirus in Beijing, China, 2014-2024.

Signal Transduct Target Ther

September 2025

Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Research Center for Respiratory Infectious Diseases, Public Health Emergency Management Innovation Center, Beijing Center for Disease Prevention and Control, Beijing, China. wangqy@bj

In November 2024, there was an unusual surge in human metapneumovirus (hMPV) infection cases in Beijing. We performed an epidemiological investigation among cases with acute respiratory tract infection (ARTI). We enrolled ARTI cases from 35 sentinel hospitals, collected samples and medical records, conducted comprehensive pathogen testing, sequenced target genes or whole genomes, and performed phylogenetic analysis.

View Article and Find Full Text PDF

Background: Human metapneumovirus (HMPV) is a common cause of acute respiratory infections. The aim of this study was to analyze the demographic characteristics and treatment outcomes of HMPV virus infection in Jilin province.

Methods: We conducted a retrospective cohort analysis of patients with respiratory tract infections between September 2023 and February 2024 in the Lequn Campus of the First Hospital of Jilin University, using tNGS sequencing.

View Article and Find Full Text PDF

Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.

Ann Allergy Asthma Immunol

September 2025

Arkansas Children's Research Institute, Little Rock, Arkansas; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas; Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas. Electronic address:

Asthma affects approximately 25 million people in the United States, with respiratory viruses playing a significant role in both the onset and exacerbations of the condition. Although rhinovirus and respiratory syncytial virus (RSV) are the most well-known triggers, other iratory viruses playing a significant role in both the on, human parainfluenza virus, human bocavirus, enterovirus D68, influenza, and SARS-CoV-2 are increasingly recognized for their significant impact on asthma. These viruses contribute to both the development of asthma and exacerbations by inducing airway inflammation, disrupting epithelial barriers, and skewing immune responses-particularly toward type 2 inflammation.

View Article and Find Full Text PDF

Introduction: Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are common viral etiologies of respiratory infections. Although co-infection with other respiratory pathogens is frequently observed, its clinical significance remains unclear.

Methods: We retrospectively analyzed 57,746 patients who underwent FILMARRAY®, a comprehensive multiplex polymerase chain reaction testing, between November 2020 and March 2023.

View Article and Find Full Text PDF

Repeated introductions and widespread transmission of human metapneumovirus in Côte d'Ivoire.

BMC Infect Dis

September 2025

Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, 20892, USA.

In Cote d'Ivoire, the incidence rate of acute respiratory infections (ARIs) rose from 165 cases per 1000 children in 2014 to more than 200 cases per 1000 children in 2015. The genetic diversity, transmission dynamics, and epidemiology of human metapneumovirus (hMPV), a causative agent of ARIs, in Cote d'Ivoire are unknown. This information is key in comprehending the transmission patterns and the role of global strains in establishing local epidemics in the country.

View Article and Find Full Text PDF